Showing results (581-590 of 696) with videos related to
Sort By:
Pageof 70
Journal of Molecular Biology|January 12, 2001
Pro-sequence assisted folding and disulfide bond formation of human nerve growth factorA Rattenholl, M Ruoppolo, A Flagiello, et al.World Journal of Pediatrics : WJP|April 5, 2024
Prospective cohort study on facial profile changes in infants with Robin sequence and healthy controlsCornelia Wiechers, Julian Sowula, Karen Kreutzer, et al.Platelets|March 8, 2003
Molecular and biochemical evidence for the presence of type III adenylyl cyclase in human plateletsPavel L Katsel, Thomas M Tagliente, Todd E Schwarz, et al.Annals of Surgical Oncology|March 7, 2003
Quality of life in patients with colorectal metastasis and intrahepatic chemotherapySarah L Blair, Marcia Grant, David Z J Chu, et al.Cancer Letters|June 3, 2019
Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancerNiranjan Awasthi, David Kronenberger, Alexis Stefaniak, et al.Annals of Surgical Oncology|January 1, 1995
Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant diseaseR E Schwarz, M C Posner, M B Plunkett, et al.Translational Oncology|February 24, 2018
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal AdenocarcinomaMd Sazzad Hassan, Niranjan Awasthi, Jun Li, et al.Environmental Science & Technology|March 8, 2008
Differences in phosphorus and nitrogen delivery to the Gulf of Mexico from the Mississippi River BasinRichard B Alexander, Richard A Smith, Gregory E Schwarz, et al.Journal of Cellular and Molecular Medicine|April 4, 2019
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancerNiranjan Awasthi, Amanda J Mikels-Vigdal, Erin Stefanutti, et al.Scientific Reports|November 28, 2019
Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinomaMd Sazzad Hassan, Fiona Williams, Niranjan Awasthi, et al.Pageof 70